
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Evidera has entered into an exclusive collaboration agreement with Clinical Study Support, Inc., a subsidiary of Shin Nippon Biomedical Laboratories Ltd. to provide research services to global or Japan-based clients undertaking studies that include a Japanese component. Additonally, they intend to explore further opportunities to expand their joint capabilities in data analytics and management, epidemiology, biostatistics, medical writing and qualitative research.
For further information, click






